AI-generated summary
The authors studied human fetal osteoblast cells treated with alendronate, a bisphosphonate, then exposed to low-level laser alone or combined with recombinant human BMP-2. They report that the combination had a synergic effect on osteoblast activity and bone matrix formation, with BMP-2 alone showing a greater effect that was not statistically significant. These findings come from a laboratory cell study and may not apply to living patients.
- Who or what was studied
- Human fetal osteoblast cell line (hFOB 1.19) treated with 100 µM alendronate in vitro
- Limits stated in the abstract
- This is an in vitro cell study, and the abstract does not report a laser wavelength, so the findings cannot be directly applied to patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jkaoms.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Collagen. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.